Investors sue Selena Gomez alleging fraud tied to her mental health startup

A singer with 400 million Instagram followers signs a contract to market a mental health app. The app never launches. The partnerships she promised never exist. For three years, the company burns investor cash and says nothing. That is the core allegation in a lawsuit filed against Selena Gomez, her mother Mandy Teefey, and Wondermind — a startup that raised $1.2 million on the premise that celebrity access equals clinical reach.

Forbes broke the story. The Cut uncovered the rot last September. Now the receipts are in a federal complaint that reads less like a business dispute and more like a post-mortem on the celebrity-founder industrial complex.

Wondermind launched in 2021 with a mission statement: daily mental health resources for everyone. The pitch deck leaned hard on Gomez's platform and her public mental health advocacy. Investors bought in. They understood the deal: Gomez would perform. She would appear. She would leverage her audience. The contract said so. Then she didn't. The complaint alleges she "ignored it" entirely. No posts. No events. No interviews. No app.

Meanwhile, Wondermind's leadership — Gomez, Teefey, and co-founder Daniella Pierson — kept the lights on with investor money. Payroll. Legal. Operations. The complaint alleges the founders knew the company was failing and said nothing. Not a board update. Not a shareholder letter. Not a single disclosure. Silence as strategy.

This pattern repeats across the wellness sector. Celebrities lend their names to startups that sell access to vulnerability. They raise on trust. They exit — or disengage — before the product ships. The investors left holding the bag are usually angels or micro-funds without the leverage to demand accountability. Gomez's investors are no exception. They are now suing for their principal back plus fees.

The mental health angle makes it sharper. Wondermind wasn't selling protein powder. It promised daily support to people managing anxiety, depression, trauma. The gap between that promise and the reality — no app, no clinicians, no content — is not just a business failure. It is a breach of the specific trust the sector demands. When a founder attaches her advocacy brand to a mental health product, she imports the moral weight of that advocacy. If the product vaporizes, the advocacy looks like marketing.

Gomez has built real credibility in this space. Her Rare Impact Fund has directed millions to youth mental health. Her documentary, her interviews, her Rare Beauty messaging — they have moved the conversation. That credibility is what Wondermind monetized. The lawsuit alleges the monetization was fraudulent: the contract existed, the obligations were clear, and the performance was zero.

Wondermind has not commented. Gomez's representatives have not commented. The silence continues.

The case will test how courts value "celebrity services" in early-stage cap tables. If a founder signs a marketing addendum and then treats it as optional, is that securities fraud? The plaintiffs say yes — the offering materials represented Gomez's involvement as material, ongoing, and binding. The defense will likely argue that founder roles evolve, that startups pivot, that marketing plans change. But the complaint alleges something more basic: the founders knew the company was dead and kept raising anyway.

That is the line regulators are starting to watch. The SEC has signaled interest in celebrity-endorsed offerings. The FTC has chased influencers who fail to disclose material connections. Now a private suit asks a jury to decide whether a famous founder's silence — while her startup spends other people's money — constitutes fraud.

The Wondermind cap table was small. $1.2 million is a rounding error for Gomez. But the precedent matters. Every celebrity founder with a side-hustle startup is watching. Every LP who wrote a check based on a TikTok following is watching. The question is whether fame buys you a different standard of disclosure.

It shouldn't. The mental health market is littered with apps that launched, promised, and vanished. Users — patients — bear the cost. Investors bear the loss. Founders move to the next thing. Gomez's next thing is a new album, a new film, a new Rare Beauty drop. Wondermind's investors have a lawsuit.

The complaint ends with a sentence that should hang in every founder's Slack: "For three years, while the Company quietly collapsed around them, not one of its founders, officers, or directors said a word to the investors whose money was funding the collapse."

That is not a startup failing. That is a startup hiding. The difference will cost Gomez more than $1.2 million if a jury agrees.